Compare CMT & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMT | MXCT |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.1M | 160.0M |
| IPO Year | N/A | 2021 |
| Metric | CMT | MXCT |
|---|---|---|
| Price | $19.82 | $0.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 23.8K | ★ 877.1K |
| Earning Date | 03-10-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $261,619,000.00 | $34,419,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.66 | $11.16 |
| P/E Ratio | $21.09 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.25 | $0.89 |
| 52 Week High | $22.29 | $4.90 |
| Indicator | CMT | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 16.96 |
| Support Level | $18.42 | $1.19 |
| Resistance Level | $19.43 | $1.28 |
| Average True Range (ATR) | 0.64 | 0.09 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 96.57 | 4.05 |
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.